Skip to main content
. 2014 Jun 3;9(6):e98796. doi: 10.1371/journal.pone.0098796

Table 1. IPD serotypes from Pakistan by age group and specimen source, 2005–2013.

Age group and syndrome Source Number of cases Serotypes (n) Proportion of serotypes included in PCV-10* (%) Proportion of serotypes included in PCV-13 (%)
0–59 months
Meningitis CSF 72 47/72 (65.3%) 48/72 (66.7%)
13 (2005–6) 19F (4), 18A/B/C/F (2), 11A/D (2), 9V/A (1), 15B/C (1), 22A/F (1), 1 (1), NT(1) 8/13 (61.5%) 8/13 (61.5%)
59 (2009–13) 18A/B/C/F (11), 14 (7), 19F (2), 23B (6), 12F/A/44/46 (6), 5 (4), 9V/A (2), 1(1), 15B/C (1), 10A (2), 6A/B/C (2), 4 (2), 23F(2), 19A (1), 17 (1), 8 (1), 9N/L (1), 24A/B/F (1), 33F/A/37 (1), 35B (1), NT (4) 39/59 (66.1%) 40/59 (67.8%)
Sepsis Blood 12 5 (3), 1 (2), 23A (2), 23F (1), 3 (1), 14 (1), 10F/C/33C (1), 35B (1) 9/12 (75%) 10/12 (83.3%)
Subtotal 84 56/84 (66.7%) 58/84 (69%)
5–15 years
Meningitis CSF 4 7A/F (1), 11A/D (1), 24A//B/F (1), NT (1) 0/4 (0%) 0/4 (0%)
Sepsis Blood 3 18A/B/C/F (1), 1 (1), 19F (1) 3/3 (100%) 3/3 (100%)
Empyema Pleural fluid 2 19F (2) 2/2 (100%) 2/2 (100%)
Subtotal 9 5/9 (55.6%) 5/9 (55.6%)
Adults (18–70 years)
Meningitis CSF 5 5 (1), 13 (1), 19F (1), 22A/F (1), NT (1) 2/5 (40%) 2/5 (40%)
Sepsis Blood 8 1 (2), 23F (2), 13 (1), 15B/C (1), 38/25F/25A (1) 4/8 (50%) 4/8 (50%
Other ** See below 5 19F (3), 1 (1), 14 (1) 5/5 (100%) 5/5 (100%)
Subtotal 18 11/18 (61.1%) 11/18 (61.1%)
TOTAL 111 72/111 (64.9%) 74/111 (66.7%)

*Includes Vaccine -related (VR) serotypes.

NT =  Non-typeable.

**Ascitic fluid (n = 3), synovial fluid (n = 1), unknown sterile body fluid (n = 1).